Differential regulation of cyclooxygenase-2 in nontransformed and Ras-transformed intestinal epithelial cells

Neoplasia

Volumn 7, Issue 8, 2005, Pages 761-770

  Du, Jianguo ^a   Jiang, Bo ^a   Barnard, John ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

COX 2; Epidermal growth factor; Ras; RhoA; Transforming growth factor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (3 BROMOANILINO) 6,7 DIMETHOXYQUINAZOLINE; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; RAS PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; PROSTAGLANDIN E2; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; DRUG INHIBITION; DRUG MECHANISM; INTESTINE EPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; CELL LINE; CELL PROLIFERATION; COMPARATIVE STUDY; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; INTESTINE MUCOSA; METABOLISM;

ANIMALS; CELL LINE; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CYCLOOXYGENASE 2; DINOPROSTONE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; INTESTINAL MUCOSA; RAS PROTEINS; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RHOA GTP-BINDING PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA;

EID: 33644698083     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.04652     Document Type: Article

References (52)

1. FitzGerald G and Patrono C (2001). The coxibs, selective inhibitors of cyclooxygenase-2. N Engl J Med 345, 433-442.
2. Eberhart CE, Coffey RJ, Radhik A, Giardiello FM, Ferrenbach S, and DuBois RN (1994). Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107, 1183-1188.
3. Williams CS, Luongo C, Radhika A, Zhang T, Lamps LW, Nanney LB, Beauchamp RD, and DuBois RN (1996). Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology 111, 1134-1140.
4. Shao J, Sheng H, Aramandla R, Pereira MA, Lubet RA, Hawk E, Grogan L, Kirsch IR, Washington MK, Beauchamp RD, et al. (1999). Coordinate regulation of cyclooxygenase-2 and TGF-beta1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors. Carcinogenesis 20, 185-191.
5. DuBois RN (2003). Cyclooxygenase-2 and colorectal cancer. Prog Exp Tumor Res 37, 124-137.
6. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB, Wakabayashi N, Saunders B, Shen Y, Fujimura T, et al. (2000). The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342, 1946-1952.
7. Jacoby RF, Cole CE, Tutsch K, Newton MA, Kelloff G, Hawk ET, and Lubet RA (2000). Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of APC mutant Min mouse adenomas, and selective toxicity against APC mutant embryos. Cancer Res 60, 1864-1870.
8. DuBois RN, Awad J, Morrow JD, Roberts LJ, and Bishop PR (1994). Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor alpha and phorbol ester. J Clin Invest 93, 493-498.
9. Han DS, Li F, Holt L, Connolly K, Hubert M, Miceli R, Okoye Z, Santiago G, Windle K, Wong E, et al. (2000). Keratinocyte growth factor-2 (FGF-10) promotes healing of experimental small intestinal ulceration in rats. Am J Physiol Gastrointest Liver Physiol 279, G1011-G1022.
10. Tessner TG, Muhale F, Schloemann S, Cohn SM, Morrison A, and Stenson WF (2003). Basic fibroblast growth factor upregulates cyclooxygenase-2 in I407 cells through p38 MAP kinase. Am J Physiol Gastrointest Liver Physiol 284, G269-G279.
11. Sheng H, Shao J, Hooten EB, Tsujii M, DuBois RN, and Beauchamp RD (1997). Cyclooxygenase-2 induction and transforming growth factor beta growth inhibition in rat intestinal epithelial cells. Cell Growth Differ 8, 463-470.
12. Jones MK, Sasaki E, Halter F, Pai R, Nakamura T, Arakawa T, Kuroki T, and Tarnawski AS (1999). HGF triggers activation of the COX-2 gene in rat gastric epithelial cells: activation mediated through the ERK2 signaling pathway. FASEB J 13, 2186-2194.
13. Xie W and Herschman HR (1996). Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum. J Biol Chem 271, 31742-31748.
14. Matsuura H, Sakaue M, Subbaramaiah K, Kamitani H, Eling TE, Dannenberg AJ, Tanabe T, Inoue H, Arata J, and Jetten AM (1999). Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. J Biol Chem 274, 29138-29148.
15. Guo YS, Cheng JZ, Jin GF, Gutkind JS, Hellmich MR, and Townsend CM Jr (2002). Gastrin stimulates cyclooxygenase-2 expression in intestinal epithelial cells through multiple signaling pathways. Evidence for involvement of ERK5 kinase and transactivation of the epidermal growth factor receptor. J Biol Chem 277, 48755-48763.
16. Sheng H, Williams CS, Shao J, Liang P, DuBois RN, and Beauchamp RD (1998). Induction of cyclooxygenase-2 by activated Ha-Ras oncogene in Rat-1 fibroblasts and the role of mitogen-activated protein kinase pathway. J Biol Chem 273, 22120-22127.
17. Slice LL, Bui L, Mak C, and Walsh JH (2000). Differential regulation of COX-2 transcription by Ras- and Rho-family of GTPases. Biochem Biophys Res Commun 276, 406-410.
18. Fujita M, Fukui H, Kusaka T, Morita K, Fujii S, Ueda Y, Chiba T, Sakamoto C, Kawamata H, and Fujimori T (2000). Relationship between cyclooxygenase-2 expression and K-ras gene mutation in colorectal adenomas. J Gastroenterol Hepatol 15, 1277-1281.
19. Sheng H, Shao J, and DuBois RN (2001). K-ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1. Cancer Res 61, 2670-2675.
20. Benitah SA, Valeron PF, and Lacal JC (2003). ROCK and nuclear factor kappaB-dependent activation of cyclooxygenase-2 by RHO GTPases: effects on tumor growth and therapeutic consequences. Mol Biol Cell 14, 3041-3054.
21. Khosravi-Far R, Campbell S, Rossman KL, and Der CJ (1998). Increasing complexity of Ras signal transduction, involvement of Rho family proteins. Adv Cancer Res 72, 57-107.
22. Gangarosa LM, Sizemore N, Graves-Deal R, Oldham SM, Der CJ, and Coffey RJ (1997). A Raf-independent epidermal growth factor receptor autocrine loop is necessary for Ras transformation of rat intestinal epithelial cells. J Biol Chem 272, 18926-18931.
23. Geiser AG, Kim SJ, Roberts AB, and Sporn MB (1991). Characterization of the mouse transforming growth factor-beta 1 promoter and activation by the Ha-Ras oncogene. Mol Cell Biol 11, 84-92.
24. Torrance C, Jackson P, Montgomery E, Kinzler KW, Vogelstein B, Wissner A, Nunes M, Frost P, and Discafani C (2000). Combinatorial chemoprevention of intestinal neoplasia. Nat Med 6, 1024-1028.
25. Blay J and Brown KD (1985). Epidermal growth factor promotes the chemotactic migration of cultured rat intestinal epithelial cells. J Cell Physiol 124, 107-112.
26. Oldham SM, Clark GJ, Gangarosa LM, Coffey JRJ, and Der CJ (1996). Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. Proc Natl Acad Sci USA 93, 6924-6928.
27. Jiang B, Zhang JS, Du J, Urrutia R, and Barnard J (2003). Growth inhibitory signalling by TGFbeta is blocked in Ras-transformed intestinal epithelial cells at a post-receptor locus. Cell Signal 15, 699-708.
28. Shipley GD, Childs CB, Volkenant ME, and Moses HL (1984). Differential effects of epidermal growth factor, transforming growth factor, and insulin on DNA and protein synthesis and morphology in serumfree cultures of AKR-2B cells. Cancer Res 44, 710-716.
29. Sheng HJS, Dixon D, Williams CS, Prescott SM, DuBois RN, and Beauchamp RD (2000). Transforming growth factor-beta1 enhances Ha-Ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. J Biol Chem 275, 6628-6635.
30. Subbaramaiah K, Telang N, Ramonetti JT, Araki R, De Vito B, Weksler BB, and Dannenberg AJ (1996). Transcription of cyclooxygenase-2 is enhanced in transformed mammary epithelial cells. Cancer Res 56, 4424-4429.
31. Polk DB, McCollum GW, and Carpenter G (1995). Cell density-dependent regulation of PLC gamma 1 tyrosine phosphorylation and catalytic activity in an intestinal cell line (IEC-6). J Cell Physiol 162, 427-433.
32. Pittelkow MR, Cook PW, Shipley GD, Derynck R, and Coffey RJ Jr (1993). Autonomous growth of human keratinocytes requires epidermal growth factor receptor occupancy. Cell Growth Differ 4, 513-521.
33. Polk DB (1998). Epidermal growth factor receptor-stimulated intestinal epithelial cell migration requires phospholipase C activity. Gastroenterology 114, 493-502.
34. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, et al. (1998). Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem 273, 8890-8896.
35. Bos M, Mendelsohn J, Kim YM, Albanell J, Fry DW, and Baselga J (1997). PD153035, a tyrosine kinase inhibitor, prevents epidermal growth factor receptor activation and inhibits growth of cancer cells in a receptor number-dependent manner. Clin Cancer Res 3, 2099-2106.
36. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F, et al. (1998). Identification of a novel inhibitor of mitogen-activated protein kinase. J Biol Chem 273, 18623-18632.
37. Du J, Jiang B, Coffey RJ, and Barnard J (2004). Raf and RhoA cooperate to transform intestinal epithelial cells and induce growth resistance to transforming growth factor beta. Mol Cancer Res 2, 233-241.
38. Kargman SL, O'Neill GP, Vickers PJ, Evans JF, Mancini JA, and Jothy S (1995). Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res 55, 2556-2559.
39. Tsujii M and DuBois RN (1995). Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83, 493-501.
40. Williams CS, Tsujii M, Reese J, Dey SK, and DuBois RN (2000). Host cyclooxygenase-2 modulates carcinoma cell growth. J Clin Invest 105, 1589-1594.
41. Oshima M, Dinchuk JE, Kargman SL, Oshima H, Hancock B, Kwong E, Trazaskos JM, Evans JF, and Taketo MM (1996). Suppression of intestinal polyposis in APC delta716 knockout mice by inhibition of cyclooxygenase-2. Cell 87, 803-809.
42. Giardello F, Yang VW, Hylind LM, Krush AJ, Petersen GM, Trimbath JD, Piantadosi S, Garrett G, Geiman DE, Hubbard W, et al. (2002). Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med 346, 1085-1087.
43. Dixon DA (2003). Regulation of COX-2 expression in human cancers. Prog Exp Tumor Res 37, 52-71.
44. Sizemore N, Cox AD, Barnard JA, Oldham SM, Reynolds ER, Der CJ, and Coffey RJ (1999). Pharmacological inhibition of Ras-transformed epithelial cell growth is linked to down-regulation of epidermal growth factor-related peptides. Gastroenterology 117, 567-576.
45. Dlugosz AA, Cheng C, Williams EK, Darwiche N, Dempsey PJ, Mann B, Dunn AR, Coffey RJ Jr, and Yuspa SH (1995). Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands. Cancer Res 55, 1883-1893.
46. Casanova ML, Larcher F, Casanova B,Murillas R, Fernandez-Acenero MJ, Villanueva C, Martinez-Palacio J, Ullrich A, Conti CJ, and Jorcano JL (2002). A critical role for ras-mediated, epidermal growth factor receptor-dependent angiogenesis in mouse skin carcinogenesis. Cancer Res 62, 3402-3407.
47. Barnard JA, Graves-Deal R, Pittelkow MR, Dubois RN, Cook P, Ramsey GW, Bishop PR, Damstrup L, and Coffey RJ (1994). Auto- and cross-induction within the mammalian epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology. Gastroenterology 108, 564-580.
48. Woo RA and Poon RYC (2004). Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation. Genes Dev 18, 1317-1330.
49. Bishop AL and Hall A (2000). Rho GTPases and their effector proteins. Biochem J 348 (Part 2), 241-255.
50. Wheeler AP and Ridley AJ (2004). Why three Rho proteins? RhoA, RhoB, RhoC, and cell motility. Exp Cell Res 301, 43-49.
51. Sinnett-Smith J, Lunn JA, Leopoldt D, and Rozengurt E (2001). Y-27632, an inhibitor of Rho-associated kinases, prevents tyrosine phosphorylation of focal adhesion kinase and paxillin induced by bombesin: dissociation from tyrosine phosphorylation of p130(CAS). Exp Cell Res 266, 292-302.
52. Walsh SV, Hopkins AM, Chen J, Narumiya S, Parkos CA, and Nusrat A (2001). Rho kinase regulates tight junction function and is necessary for tight junction assembly in polarized intestinal epithelia. Gastroenterology 121, 566-579.